Documents
A list of downloadable documents created during development.
Background information
Macular oedema (diabetic) - ranibizumab (rapid review of TA237): equality impact assessment - guidance development
Macular oedema (diabetic) - ranibizumab (rapid review of TA237): final appraisal determination
-
Macular oedema (diabetic) - ranibizumab (rapid review of TA237): consultee and commentator comments on the ACD
Macular oedema (diabetic) - ranibizumab (rapid review of TA237): appraisal consultation
-
Macular oedema (diabetic) - ranibizumab (rapid review of TA237): appraisal consultation
-
Macular oedema (diabetic) - ranibizumab (rapid review of TA237): evaluation report